EKF.L
EKF Diagnostics Holdings plc
LSEGBpEQUITY
Healthcare
DELAYED
Last price
25.27
▼ 0.13 (0.52%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
25.40
Prev close
25.40
Day high
25.40
Day low
24.80
Volume
90.05K
Market cap
$108.37M
P/E (TTM)
—
52W range
21.80 – 32.00
Day trading desk
Gap from prior close
0.00%
Prior close 25.40
VWAP
25.08
+0.75% from price
Relative volume
0.52×
Quiet session
Session range
2.41%
24.80 – 25.40
Position in range
78%
Near session high
ATR (14D)
1.03
4.06% of price
Prior day high
25.40
PDH
Prior day low
24.70
PDL
Bid / ask spread
—
Quote not published
Session volume
134.16K
Avg 255.76K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.47%
+2.7%
1M
-1.69%
-5.0%
3M
-7.11%
-9.5%
6M
-4.29%
-16.2%
YTD
-4.29%
-16.3%
1Y
-11.34%
-31.5%
3Y
-5.90%
-80.9%
5Y
-67.71%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EKF.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
17.09M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | Oryx International Growth Fund Limited |
— | 0 | — | Direct |
| Jun 30, 26 | Rigg (Christian Alexander) |
— | 0 | — | Direct |
| Jun 30, 26 | Ruffer LLP |
— | 0 | — | Direct |
| Jun 30, 26 | Schroder Investment Management, Ltd. |
— | 0 | — | Direct |
| Jun 30, 26 | Winter (Jennifer Ann Julia) |
— | 0 | — | Direct |
| Jun 30, 26 | Baines (Julian Huw) |
— | 0 | — | Direct |
| Jun 30, 26 | Gresham House Plc |
— | 0 | — | Direct |
| Jun 30, 26 | Jones (Gavin) |
— | 0 | — | Direct |
| Jun 30, 26 | Liontrust Asset Management Plc |
— | 0 | — | Direct |
| Jun 30, 26 | Morgan Stanley |
— | 0 | — | Direct |
| May 6, 26 | Jones (Gavin) |
— | 0 | — | Direct |
| May 6, 26 | Oryx International Growth Fund Limited |
— | 0 | — | Direct |
| May 6, 26 | Rigg (Christian Alexander) |
— | 0 | — | Direct |
| May 6, 26 | Winter (Jennifer Ann Julia) |
— | 0 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Baines (Julian Huw) |
— | 1.75M | Annual Return |
EKF Diagnostics Holdings PLC |
— | 1.06M | Buy Back |
Gresham House Plc |
— | 51.14M | Annual Return |
Liontrust Asset Management Plc |
— | 40.91M | Annual Return |
Morgan Stanley |
— | 14.38M | Annual Return |
Oryx International Growth Fund Limited |
— | 127.05M | Annual Return |
Ruffer LLP |
— | 27.64M | Annual Return |
Schroder Investment Management, Ltd. |
— | 23.72M | Annual Return |
Stockinvest Ltd |
— | 19.38M | Annual Return |
Winter (Jennifer Ann Julia) |
— | 150.00K | Annual Return |
Fundamentals
Market cap$108.37M
Enterprise value$99.12M
Revenue (TTM)$51.56M
Gross profit$26.48M
EBITDA$10.16M
Net income$2.12M
EPS (TTM)$0.00
Free cash flow$6.67M
Total cash$13.69M
Total debt$1.39M
Book value / share$0.16
Shares outstanding428.92M
Float351.26M
Short % of float—
Dividend yield—
Beta (5Y)0.50
Valuation & profitability ratios
Trailing P/E—
Forward P/E13.82
PEG ratio—
Price / sales—
Price / book158.91
EV / revenue1.92
EV / EBITDA9.76
Gross margin51.35%
Operating margin12.88%
Profit margin4.11%
Return on equity3.53%
Return on assets5.36%
Debt / equity1.97
Current ratio4.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $51.56M | $50.19M | $52.61M | $66.64M | +2.7% |
| Operating revenue | $51.56M | $50.19M | $52.61M | $66.64M | +2.7% |
| Cost of revenue | $25.08M | $26.13M | $28.75M | $42.60M | -4.0% |
| Gross profit | $26.48M | $24.07M | $23.86M | $24.04M | +10.0% |
| Selling, general & admin | $19.73M | $18.08M | $19.68M | $23.18M | +9.2% |
| Total operating expense | $19.50M | $17.78M | $19.52M | $22.26M | +9.7% |
| Operating income | $6.98M | $6.28M | $4.34M | $1.78M | +11.1% |
| Net interest income | $108.00K | $3.00K | $50.00K | $29.00K | +3,500.0% |
| Pre-tax income | $7.09M | $6.26M | $2.13M | -$8.94M | +13.1% |
| Tax provision | $4.55M | -$314.00K | -$600.00K | $634.00K | +1,550.6% |
| Net income | $2.12M | $6.24M | $2.35M | -$10.10M | -66.0% |
| Net income to common | $2.12M | $6.24M | $2.35M | -$10.10M | -66.0% |
| Basic EPS | 0.00 | 0.01 | 0.01 | -0.02 | -65.9% |
| Diluted EPS | 0.00 | 0.01 | 0.01 | -0.02 | -65.9% |
| EBIT | $7.24M | $6.43M | $2.21M | -$8.84M | +12.5% |
| EBITDA | $12.64M | $11.16M | $7.68M | -$2.18M | +13.2% |
| Basic shares | 448.33M | 453.73M | 454.11M | 457.18M | -1.2% |
| Diluted shares | 448.47M | 453.73M | 454.11M | 457.18M | -1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.69M | $13.01M | $6.02M | $9.21M | — | +5.2% |
| Cash & short-term investments | $13.69M | $13.01M | $6.02M | $9.21M | — | +5.2% |
| Accounts receivable | $5.33M | $5.84M | $5.63M | $7.86M | — | -8.8% |
| Inventory | $8.30M | $7.39M | $8.77M | $9.43M | — | +12.3% |
| Total current assets | $30.88M | $28.55M | $25.56M | $31.76M | — | +8.1% |
| Property, plant & equipment | $22.30M | $24.03M | $24.77M | $21.71M | — | -7.2% |
| Goodwill & intangibles | $27.88M | $28.92M | $30.22M | $33.77M | — | -3.6% |
| Total assets | $81.14M | $81.75M | $80.85M | $89.29M | — | -0.7% |
| Total current liabilities | $7.42M | $6.44M | $9.50M | $11.74M | — | +15.3% |
| Current debt | — | $0 | $2.99M | $137.00K | $265.00K | — |
| Long-term debt | — | $0 | $0 | $0 | $431.00K | — |
| Total debt | $1.39M | $1.32M | $4.10M | $1.55M | — | +5.1% |
| Total liabilities | $10.86M | $8.53M | $12.63M | $14.77M | — | +27.3% |
| Retained earnings | $52.14M | $55.00M | $48.76M | $52.46M | — | -5.2% |
| Shareholder equity | $69.05M | $72.33M | $67.12M | $73.35M | — | -4.5% |
| Working capital | $23.45M | $22.11M | $16.06M | $20.02M | — | +6.1% |
| Net tangible assets | $41.17M | $43.41M | $36.89M | $39.57M | — | -5.2% |
| Shares issued | 435.38M | 454.93M | 454.93M | 454.93M | — | -4.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $7.09M | $6.26M | $2.13M | -$8.94M | — | +13.1% |
| Depreciation & amortisation | $5.40M | $4.72M | $5.47M | $6.66M | — | +14.2% |
| Stock-based compensation | $14.00K | $0 | -$2.00K | -$308.00K | — | — |
| Change in working capital | -$513.00K | $665.00K | -$1.05M | -$1.72M | — | -177.1% |
| Operating cash flow | $9.71M | $13.66M | $6.31M | $9.69M | — | -28.9% |
| Capital expenditure | -$2.37M | -$2.76M | -$6.97M | -$5.83M | — | +14.1% |
| Investing cash flow | -$2.34M | -$2.66M | -$5.64M | -$8.93M | — | +12.2% |
| Share buybacks | -$4.99M | $0 | $0 | -$3.90M | — | — |
| Dividends paid | — | — | -$5.45M | -$5.46M | -$5.10M | — |
| Financing cash flow | -$5.86M | -$4.08M | -$3.65M | -$11.04M | — | -43.8% |
| Free cash flow | $7.34M | $10.90M | -$664.00K | $3.86M | — | -32.7% |
| End cash position | $15.83M | $14.30M | $7.73M | $11.58M | — | +10.7% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $13.69M | $14.67M | $13.01M | -6.7% |
| Cash & short-term investments | $13.69M | $14.67M | $13.01M | -6.7% |
| Accounts receivable | $5.33M | $7.09M | $5.84M | -24.8% |
| Inventory | $8.30M | $7.83M | $7.39M | +6.1% |
| Total current assets | $30.88M | $31.53M | $28.55M | -2.1% |
| Property, plant & equipment | $22.30M | $21.88M | $24.03M | +1.9% |
| Goodwill & intangibles | $27.88M | $28.79M | $28.92M | -3.2% |
| Total assets | $81.14M | $82.43M | $81.75M | -1.6% |
| Total current liabilities | $7.42M | $6.82M | $6.44M | +8.7% |
| Current debt | — | — | $0 | — |
| Long-term debt | — | — | $0 | — |
| Total debt | $1.39M | $1.12M | $1.32M | +23.4% |
| Total liabilities | $10.86M | $9.55M | $8.53M | +13.7% |
| Retained earnings | $52.14M | $55.95M | $55.00M | -6.8% |
| Shareholder equity | $69.05M | $71.73M | $72.33M | -3.7% |
| Working capital | $23.45M | $24.71M | $22.11M | -5.1% |
| Net tangible assets | $41.17M | $42.94M | $43.41M | -4.1% |
| Shares issued | 435.38M | 449.09M | 454.93M | -3.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 0.02 | 3 | $54.59M | +5.9% |
| Next year | 0.02 | 3 | $58.34M | +6.9% |
Analyst targets & ownership
Mean target$34.67
High target$35.00
Low target$34.00
Implied upside37.20%
Analyst count3
ConsensusNONE
Strong buy / Buy0 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders3.94%
Held by institutions73.66%
Institutions holding23
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.20
+0.28% from price
SMA 20
25.48
-0.85% from price
SMA 50
25.82
-2.13% from price
SMA 100
25.75
-1.86% from price
SMA 200
25.53
-1.03% from price
EMA 12
25.27
-0.02% from price
EMA 26
25.46
-0.76% from price
EMA 50
25.63
-1.43% from price
RSI (14)
47.7
Neutral
MACD (12,26,9)
-0.19
Hist -0.01
ATR (14)
1.03
4.06% of price
Realised vol 30D
24.9%
Annualised
Bollinger upper
26.32
20, 2σ
Bollinger lower
24.65
20, 2σ
50 / 200 cross
Golden
25.82 vs 25.53
Trend bias
Below 200
-1.03%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.04
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
24.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-31.7%
Peak to trough
Max drawdown 5Y
-77.7%
Peak to trough
ATR 14
1.03
4.06% of price
Beta (reported)
0.50
5Y monthly, from filing
Headlines
Micron's Big AI Test Is Coming This Week
GuruFocus.com · 2m ago
Alibaba Slides as $10.2 Billion AI Sale Dilutes Investors
GuruFocus.com · 3m ago
Jersey Mike's Subs Same-Store Sales Growth More Durable Than Peers, RBC Says
MT Newswires · 4m ago
HearingLife Introduces Oticon Reveal, the World's First Dual AI-Powered Hearing Aid
PR Newswire · 4m ago
France readies high school phone ban for next month
AFP · 5m ago
DeepCura Unveils the Electronic Health Workforce (EHW) -- the Step Beyond the EHR
PR Newswire · 7m ago
Shipping ETF (SEA) Hits New 52-Week High
Zacks · 8m ago
Is PepsiCo's Growth Story Becoming More Internationally Focused?
Zacks · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.